Work

Faculty Opinions recommendation of The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.

Year: 2016

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.726861250.793525591

Authors: Scott Kaufmann, Cordelia McGehee

Institution: Mayo Clinic

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4231048427

Cites:

Cited by:

Related to: 10